About china sxt pharmaceuticals inc - SXTC
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
SXTC At a Glance
China Sxt Pharmaceuticals, Inc.
178 Taidong North Road
Taizhou, Jiangsu 225300
| Phone | 86-523-86299087 | Revenue | 1.74M | |
| Industry | Pharmaceuticals: Major | Net Income | -3,303,652.00 | |
| Sector | Health Technology | Employees | 75 | |
| Fiscal Year-end | 03 / 2026 | |||
| View SEC Filings |
SXTC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.04 |
| Price to Book Ratio | 2.224 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 8.539 |
| Enterprise Value to Sales | -7.809 |
| Total Debt to Enterprise Value | -0.072 |
SXTC Efficiency
| Revenue/Employee | 23,212.093 |
| Income Per Employee | -44,048.693 |
| Receivables Turnover | 1.338 |
| Total Asset Turnover | 0.078 |
SXTC Liquidity
| Current Ratio | 3.542 |
| Quick Ratio | 3.354 |
| Cash Ratio | 3.016 |
SXTC Profitability
| Gross Margin | 21.105 |
| Operating Margin | -96.181 |
| Pretax Margin | -189.766 |
| Net Margin | -189.766 |
| Return on Assets | -14.752 |
| Return on Equity | -22.497 |
| Return on Total Capital | -20.115 |
| Return on Invested Capital | -22.115 |
SXTC Capital Structure
| Total Debt to Total Equity | 6.372 |
| Total Debt to Total Capital | 5.991 |
| Total Debt to Total Assets | 4.542 |
| Long-Term Debt to Equity | 1.371 |
| Long-Term Debt to Total Capital | 1.289 |